Loading…
Novelties in the Field of Anti-Infective Compounds in 1999
In 1999 the number of new compounds reported in the anti-infective field decreased significantly in comparison with previous years, especially for antifungals. The reported new compounds are mainly directed against Staphylococcus aureus isolates resistant to methicillin. Few derivatives were reporte...
Saved in:
| Published in: | Clinical infectious diseases 2000-12, Vol.31 (6), p.1423-1466 |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c546t-ec40be0757abc0f2cb3d2700cac7caf236c521b7d1e5cb22f907cc2e8a3637203 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c546t-ec40be0757abc0f2cb3d2700cac7caf236c521b7d1e5cb22f907cc2e8a3637203 |
| container_end_page | 1466 |
| container_issue | 6 |
| container_start_page | 1423 |
| container_title | Clinical infectious diseases |
| container_volume | 31 |
| creator | Bryskier, André |
| description | In 1999 the number of new compounds reported in the anti-infective field decreased significantly in comparison with previous years, especially for antifungals. The reported new compounds are mainly directed against Staphylococcus aureus isolates resistant to methicillin. Few derivatives were reported in the field of anti-infectives for gram-negative bacteria. At the moment, we are in a period of discovery as we await novel compounds that could issue from new engineering. |
| doi_str_mv | 10.1086/317490 |
| format | article |
| fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_72437921</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>4482386</jstor_id><oup_id>10.1086/317490</oup_id><sourcerecordid>4482386</sourcerecordid><originalsourceid>FETCH-LOGICAL-c546t-ec40be0757abc0f2cb3d2700cac7caf236c521b7d1e5cb22f907cc2e8a3637203</originalsourceid><addsrcrecordid>eNqF0F1L3EAUBuBBlPrR-gtEIoJ3sWdmMl-9k0XdRWlvLBRvhsnkBEezmW0mEfvvTZtl6414dQ68D-fAS8ghhXMKWn7lVBUGtsgeFVzlUhi6Pe4gdF5ornfJfkqPAJRqEJ_ILqVgJFC-R759j8_Y9AFTFtqsf8DsKmBTZbHOLto-5Iu2Rt-HZ8xmcbmKQ1v9g9QY85ns1K5J-GU9D8jPq8u72Ty__XG9mF3c5l4Uss_RF1AiKKFc6aFmvuQVUwDeeeVdzbj0gtFSVRSFLxmrDSjvGWrHJVcM-AE5m-6uuvh7wNTbZUgem8a1GIdkFSu4Mox-CKnSRkr5BvouptRhbVddWLruj6Vg_9ZppzpHeLy-OJRLrP6zdX8jOF0Dl7xr6s61PqSN0wUAZ6M6mVQcVu-_OprMY-pjt1FFoRnXcozzKQ6px5dN7LonKxVXws5_3Vsu4V7pmxt7x18BpWmbVg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17896661</pqid></control><display><type>article</type><title>Novelties in the Field of Anti-Infective Compounds in 1999</title><source>JSTOR Archival Journals and Primary Sources Collection</source><source>Oxford University Press:Jisc Collections:OUP Read and Publish 2024-2025 (2024 collection) (Reading list)</source><creator>Bryskier, André</creator><creatorcontrib>Bryskier, André</creatorcontrib><description>In 1999 the number of new compounds reported in the anti-infective field decreased significantly in comparison with previous years, especially for antifungals. The reported new compounds are mainly directed against Staphylococcus aureus isolates resistant to methicillin. Few derivatives were reported in the field of anti-infectives for gram-negative bacteria. At the moment, we are in a period of discovery as we await novel compounds that could issue from new engineering.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1086/317490</identifier><identifier>PMID: 11096013</identifier><identifier>CODEN: CIDIEL</identifier><language>eng</language><publisher>Chicago, IL: The University of Chicago Press</publisher><subject>American culture ; Animals ; Anti-Bacterial Agents - chemistry ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Antibacterials ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antimicrobials ; Bacteria - drug effects ; Biological and medical sciences ; Carbapenems ; Chemotherapy ; Drugs, Investigational - chemistry ; Drugs, Investigational - pharmacology ; Drugs, Investigational - therapeutic use ; Eukaryota - drug effects ; Fluoroquinolones ; Gram positive cocci ; Humans ; Infection - drug therapy ; Ketolides ; Medical sciences ; Microbiology ; Miscellaneous. Antibiotics with multiple activities ; Penicillin ; Pharmacology. Drug treatments ; Special Section: Clinical Practice ; Staphylococcus aureus</subject><ispartof>Clinical infectious diseases, 2000-12, Vol.31 (6), p.1423-1466</ispartof><rights>Copyright 2000 The Infectious Diseases Society of America</rights><rights>2000 by the Infectious Diseases Society of America 2000</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c546t-ec40be0757abc0f2cb3d2700cac7caf236c521b7d1e5cb22f907cc2e8a3637203</citedby><cites>FETCH-LOGICAL-c546t-ec40be0757abc0f2cb3d2700cac7caf236c521b7d1e5cb22f907cc2e8a3637203</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/4482386$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/4482386$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,58238,58471</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=840032$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11096013$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bryskier, André</creatorcontrib><title>Novelties in the Field of Anti-Infective Compounds in 1999</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><addtitle>Clinical Infectious Diseases</addtitle><description>In 1999 the number of new compounds reported in the anti-infective field decreased significantly in comparison with previous years, especially for antifungals. The reported new compounds are mainly directed against Staphylococcus aureus isolates resistant to methicillin. Few derivatives were reported in the field of anti-infectives for gram-negative bacteria. At the moment, we are in a period of discovery as we await novel compounds that could issue from new engineering.</description><subject>American culture</subject><subject>Animals</subject><subject>Anti-Bacterial Agents - chemistry</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibacterials</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antimicrobials</subject><subject>Bacteria - drug effects</subject><subject>Biological and medical sciences</subject><subject>Carbapenems</subject><subject>Chemotherapy</subject><subject>Drugs, Investigational - chemistry</subject><subject>Drugs, Investigational - pharmacology</subject><subject>Drugs, Investigational - therapeutic use</subject><subject>Eukaryota - drug effects</subject><subject>Fluoroquinolones</subject><subject>Gram positive cocci</subject><subject>Humans</subject><subject>Infection - drug therapy</subject><subject>Ketolides</subject><subject>Medical sciences</subject><subject>Microbiology</subject><subject>Miscellaneous. Antibiotics with multiple activities</subject><subject>Penicillin</subject><subject>Pharmacology. Drug treatments</subject><subject>Special Section: Clinical Practice</subject><subject>Staphylococcus aureus</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNqF0F1L3EAUBuBBlPrR-gtEIoJ3sWdmMl-9k0XdRWlvLBRvhsnkBEezmW0mEfvvTZtl6414dQ68D-fAS8ghhXMKWn7lVBUGtsgeFVzlUhi6Pe4gdF5ornfJfkqPAJRqEJ_ILqVgJFC-R759j8_Y9AFTFtqsf8DsKmBTZbHOLto-5Iu2Rt-HZ8xmcbmKQ1v9g9QY85ns1K5J-GU9D8jPq8u72Ty__XG9mF3c5l4Uss_RF1AiKKFc6aFmvuQVUwDeeeVdzbj0gtFSVRSFLxmrDSjvGWrHJVcM-AE5m-6uuvh7wNTbZUgem8a1GIdkFSu4Mox-CKnSRkr5BvouptRhbVddWLruj6Vg_9ZppzpHeLy-OJRLrP6zdX8jOF0Dl7xr6s61PqSN0wUAZ6M6mVQcVu-_OprMY-pjt1FFoRnXcozzKQ6px5dN7LonKxVXws5_3Vsu4V7pmxt7x18BpWmbVg</recordid><startdate>20001201</startdate><enddate>20001201</enddate><creator>Bryskier, André</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>20001201</creationdate><title>Novelties in the Field of Anti-Infective Compounds in 1999</title><author>Bryskier, André</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c546t-ec40be0757abc0f2cb3d2700cac7caf236c521b7d1e5cb22f907cc2e8a3637203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>American culture</topic><topic>Animals</topic><topic>Anti-Bacterial Agents - chemistry</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibacterials</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antimicrobials</topic><topic>Bacteria - drug effects</topic><topic>Biological and medical sciences</topic><topic>Carbapenems</topic><topic>Chemotherapy</topic><topic>Drugs, Investigational - chemistry</topic><topic>Drugs, Investigational - pharmacology</topic><topic>Drugs, Investigational - therapeutic use</topic><topic>Eukaryota - drug effects</topic><topic>Fluoroquinolones</topic><topic>Gram positive cocci</topic><topic>Humans</topic><topic>Infection - drug therapy</topic><topic>Ketolides</topic><topic>Medical sciences</topic><topic>Microbiology</topic><topic>Miscellaneous. Antibiotics with multiple activities</topic><topic>Penicillin</topic><topic>Pharmacology. Drug treatments</topic><topic>Special Section: Clinical Practice</topic><topic>Staphylococcus aureus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bryskier, André</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bryskier, André</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novelties in the Field of Anti-Infective Compounds in 1999</atitle><jtitle>Clinical infectious diseases</jtitle><stitle>Clinical Infectious Diseases</stitle><addtitle>Clinical Infectious Diseases</addtitle><date>2000-12-01</date><risdate>2000</risdate><volume>31</volume><issue>6</issue><spage>1423</spage><epage>1466</epage><pages>1423-1466</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><coden>CIDIEL</coden><abstract>In 1999 the number of new compounds reported in the anti-infective field decreased significantly in comparison with previous years, especially for antifungals. The reported new compounds are mainly directed against Staphylococcus aureus isolates resistant to methicillin. Few derivatives were reported in the field of anti-infectives for gram-negative bacteria. At the moment, we are in a period of discovery as we await novel compounds that could issue from new engineering.</abstract><cop>Chicago, IL</cop><pub>The University of Chicago Press</pub><pmid>11096013</pmid><doi>10.1086/317490</doi><tpages>44</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1058-4838 |
| ispartof | Clinical infectious diseases, 2000-12, Vol.31 (6), p.1423-1466 |
| issn | 1058-4838 1537-6591 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72437921 |
| source | JSTOR Archival Journals and Primary Sources Collection; Oxford University Press:Jisc Collections:OUP Read and Publish 2024-2025 (2024 collection) (Reading list) |
| subjects | American culture Animals Anti-Bacterial Agents - chemistry Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Antibacterials Antibiotics. Antiinfectious agents. Antiparasitic agents Antimicrobials Bacteria - drug effects Biological and medical sciences Carbapenems Chemotherapy Drugs, Investigational - chemistry Drugs, Investigational - pharmacology Drugs, Investigational - therapeutic use Eukaryota - drug effects Fluoroquinolones Gram positive cocci Humans Infection - drug therapy Ketolides Medical sciences Microbiology Miscellaneous. Antibiotics with multiple activities Penicillin Pharmacology. Drug treatments Special Section: Clinical Practice Staphylococcus aureus |
| title | Novelties in the Field of Anti-Infective Compounds in 1999 |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T17%3A17%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novelties%20in%20the%20Field%20of%20Anti-Infective%20Compounds%20in%201999&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Bryskier,%20Andr%C3%A9&rft.date=2000-12-01&rft.volume=31&rft.issue=6&rft.spage=1423&rft.epage=1466&rft.pages=1423-1466&rft.issn=1058-4838&rft.eissn=1537-6591&rft.coden=CIDIEL&rft_id=info:doi/10.1086/317490&rft_dat=%3Cjstor_proqu%3E4482386%3C/jstor_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c546t-ec40be0757abc0f2cb3d2700cac7caf236c521b7d1e5cb22f907cc2e8a3637203%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17896661&rft_id=info:pmid/11096013&rft_jstor_id=4482386&rft_oup_id=10.1086/317490&rfr_iscdi=true |